Morris EB, Shelso J, Smeltzer MP, Thomas NA, Karimova EJ, Li CS, Merchant T, Gajjar A, Kaste SC. The use of bone age for bone mineral density interpretation in a cohort of pediatric brain tumor patients.
Pediatr Radiol 2008;
38:1285-92. [PMID:
18769909 DOI:
10.1007/s00247-008-0991-x]
[Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/13/2008] [Revised: 07/31/2008] [Accepted: 08/11/2008] [Indexed: 11/25/2022]
Abstract
BACKGROUND
Skeletal bone accretion occurs throughout childhood. The integrity of this process can influence future adult bone health and the risk of osteoporosis. Although surveillance of children who are at risk of poor bone accretion is important, the most appropriate method to monitor childhood bone health has not been established. Previous investigators have proposed using bone age (BA) rather than chronological age (CA) when interpreting bone mineral density (BMD) values in children.
OBJECTIVE
To investigate the value of BA assessment for BMD measurement in a cohort of children at risk of poor accretion.
MATERIALS AND METHODS
A cohort of 163 children with brain tumors who completed both a BMD assessment (quantitative computed tomography, QCT) and who had a BA within a 6-month interval were identified. The difference in BMD Z-scores determined by CA and BA was determined. The impact of salient clinical features was assessed.
RESULTS
No significant difference between CA and BA Z-scores was detected in the overall cohort (P = 0.056). However, the scores in 18 children (all boys between the ages of 11 years and 15 years) were statistically determined to be outliers from the values in the rest of the cohort.
CONCLUSION
Interpretation of BMD with BA measurement might be appropriate and affect treatment decisions in peripubertal males.
Collapse